Inmed PharmaceuticalsINM
13F holders, Q2 2026 (June 30)20holders +11
13new positions
2sold out
1famous investor
$1.55avg. 13F price*
At the end of Q2 2026, 20 institutions reported holding Inmed Pharmaceuticals Inc. (INM) in their 13F filings, up 11 from Q1 2026. 13 opened new positions and 2 sold out. The largest holders were ADAR1 Capital Management, LLC ($1.2M), Vivo Capital, LLC ($1.2M) and Squadron Capital Management LLC ($504K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Inmed Pharmaceuticals Inc.
- CUSIP
- 457637700
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $4.0M |
| Exits | 2 | $18K |
All 13F filers, Q1 2026 → Q2 2026: 2,610,330 shares bought and 232,000 shares sold, net +2,378,330 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
"% of holder's portfolio" is INM's weight in each manager's 13F, not the share of Inmed Pharmaceuticals Inc. the manager owns.